Max Rady College of Medicine

View reference

Printer friendly

Bernstein CN, Blanchard JF, Metge C, Yogendran M. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer? Am J Gastroenterol 2003;98(12):2784-2788. [Abstract]

Related concepts

Dose Intensity
Inflammatory Bowel Disease (IBD) - Defining in Administrative Data

Related terms

Drug Program Information Network (DPIN)
Inflammatory Bowel Disease (IBD)
Prescribed Daily Dose (PDD)


Irritable Bowel Syndrome
Manitoba Studies

Request information in an accessible format

If you require access to our resources in a different format, please contact us:

We strive to provide accommodations upon request in a reasonable timeframe.

Contact us

Manitoba Centre for Health Policy
Community Health Sciences, Max Rady College of Medicine,
Rady Faculty of Health Sciences,
Room 408-727 McDermot Ave.
University of Manitoba
Winnipeg, MB R3E 3P5 Canada